Efficacy and safety of double-dose aumolertinib in advanced EGFR-mutant NSCLC with distinct post–first-line EGFR-TKI progression patterns: A prospective, open-label, multicenter study

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

R. Zhong 1; L. Xiong 2; X. Zhang 1; W. Zhang 1; Y. Zhang 1; W. Nie 2; Y. Lou 3; T. Chu 1; H. Zhong 1

Feb 5, 2026